TY  - RPRT
TI  - Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
AU  - Diez, J. M.
AU  - Romero, C.
AU  - Vergara Alert, J.
AU  - Bello Perez, M.
AU  - Rodon, J.
AU  - Honrubia, J. M.
AU  - Segales, J.
AU  - Sola, I.
AU  - Enjuanes, L.
AU  - Gajardo, R.
PY  - 2020
DO  - 10.1101/2020.06.19.160879
UR  - https://www.biorxiv.org/content/10.1101/2020.06.19.160879v1
ID  - 10.1101/2020.06.19.160879
ER  -